Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Summary

RATIONALE: Current therapies for Glioblastoma Multiforme provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of brain tumors. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adults (≥ 18 years of age) with newly diagnosed Glioblastoma Multiforme.

Timeline

Start

1995-03-14

Primary completion

2004-12-07

Completion

2004-12-07

Drugs

Indications